In this issue:
- Finerenone with empagliflozin in CKD and type 2 diabetes
- Finerenone for acute eGFR change
- Combination therapy: new standard of care in diabetic and nondiabetic CKD
- Treatment of IgA nephropathy: call for a new paradigm
- Long-term outcomes of rituximab for podocytopathies
- Kidney function decline and congestion status after heart failure discharge
- Limits of permissive hypercreatininaemia during decongestion in heart failure
- Effects of pantoprazole on kidney outcomes
- Genomic testing in patients with kidney failure of unknown cause
- Updated thiazide diuretic evidence for kidney stone recommendations
Please login below to download this issue (PDF)